Algert Global LLC Rapt Therapeutics, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 47,483 shares of RAPT stock, worth $41,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,483

Previous 47,483 -0.0%

Holding current value

$41,785

Previous $145,000 34.48%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.89 - $9.38 $18,510 - $60,078	-6,405 Reduced 11.89%	47,483 $145,000
Q1 2024 May 14, 2024	BUY	$6.87 - $26.45 $128,867 - $496,149	18,758 Added 53.4%	53,888 $484,000
Q4 2023 Feb 14, 2024	SELL	$11.28 - $25.46 $302,992 - $683,881	-26,861 Reduced 43.33%	35,130 $873,000
Q3 2023 Nov 13, 2023	SELL	$16.34 - $24.66 $219,773 - $331,677	-13,450 Reduced 17.83%	61,991 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $23,929 - $32,198	1,490 Added 2.01%	75,441 $1.41 Million
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $91,003 - $163,055	5,294 Added 7.71%	73,951 $1.36 Million
Q4 2022 Feb 13, 2023	BUY	$16.28 - $24.6 $895,074 - $1.35 Million	54,980 Added 401.99%	68,657 $1.36 Million
Q3 2022 Nov 15, 2022	BUY	$17.96 - $30.46 $37,931 - $64,331	2,112 Added 18.26%	13,677 $329,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $23.59 $118,656 - $272,818	11,565 New	11,565 $211,000
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $329,102 - $440,662	-11,156 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $70,350 - $92,991	2,356 Added 26.77%	11,156 $346,000
Q2 2021 Aug 13, 2021	SELL	$17.99 - $40.02 $133,665 - $297,348	-7,430 Reduced 45.78%	8,800 $280,000
Q1 2021 May 14, 2021	BUY	$16.0 - $24.46 $259,680 - $396,985	16,230 New	16,230 $360,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Rapt Therapeutics, Inc. Transaction History